Lifecore Biomedical logo
Lifecore Biomedical
LFCR | NASDAQ
Chart Builder DCF Calculator
$6.42
$0.00 (0.00%)
At close: Nov 16, 2026, 4:00 PM ET
$6.42
$0.00 (-0.08%)
After-hours: Nov 16, 2026, 4:10 PM ET

Lifecore Biomedical Company Profile

Company profile explained

Company Profile

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Key Executives

Name Position
Paul Josephs President, Chief Executive Officer & Director
Ryan D. Lake Executive Vice President & Chief Financial Officer
Aaron Perlitsh Director of Internal Audit & Chief Compliance Officer
Jackie Q. Klecker Executive Vice President of Quality & Development Services
Mark DaFonseca Chief Commercial Officer
Parker K. Javid Vice President
Thomas Guldager Vice President of Operations
Thomas Salus Chief Legal and Administration Officer & Corporate Secretary

Latest SEC Filings

Date Type Title
Oct 30, 2026 PREM14A Filing
Oct 20, 2026 8-K Current Report
Sep 29, 2026 SC 13D/A [Amend] Filing
Sep 29, 2026 8-K Current Report
Sep 28, 2026 SC 13D/A [Amend] Filing
Sep 28, 2026 DEFA14A Filing
Sep 28, 2026 8-K Current Report
Aug 05, 2026 10-Q Quarterly Report
Aug 05, 2026 8-K Current Report
Jul 29, 2026 SC 13G Statement of acquisition of beneficial ownership b...
View All SEC Filings ➞
Lifecore Biomedical
Lifecore Biomedical logo
Country United States
IPO Date Feb 15, 1996
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 382
CEO Paul Josephs

Contact Details

3515 Lyman Boulevard Chaska, Minnesota 55318 United States

Stock Details

Ticker Symbol LFCR
Exchange NASDAQ
Fiscal Year June - May
Reporting Currency USD
CIK Code 0001005286
CUSIP Number 514766104
ISIN Number US5147661046
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.